Literature DB >> 27003988

Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas.

Ian W Folkert1, Paul Hernandez1, Robert E Roses1.   

Abstract

Pancreatic neuroendocrine tumors (PNETs) are a rare and diverse group of tumors; nonfunctional (NF) PNETs account for the majority of cases. Most patients with NF-PNETs have metastatic disease at the time of presentation. A variety of treatment modalities exist, including medical, liver directed, and surgical treatments. Aggressive surgical management is associated with prolonged survival, however available data are limited by selection bias and the frequent combination of PNETs with carcinoid tumors. Although few patients with metastatic disease will be cured, application of currently available therapies in a multidisciplinary setting can lead to excellent outcomes with prolonged patient survival.

Entities:  

Keywords:  Multidisciplinary; Neuroendocrine tumor; Nonfunctional; Pancreas; Pancreatic neuroendocrine tumor

Mesh:

Year:  2016        PMID: 27003988      PMCID: PMC4789986          DOI: 10.3748/wjg.v22.i11.3105

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  90 in total

1.  Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors.

Authors:  Sébastien Gaujoux; Stefano Partelli; Frédérique Maire; Mirko D'Onofrio; Béatrice Larroque; Domenico Tamburrino; Alain Sauvanet; Massimo Falconi; Philippe Ruszniewski
Journal:  J Clin Endocrinol Metab       Date:  2013-09-20       Impact factor: 5.958

2.  Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: long-term follow-up.

Authors:  Hizir Yakup Akyildiz; Jamie Mitchell; Mira Milas; Allan Siperstein; Eren Berber
Journal:  Surgery       Date:  2010-12       Impact factor: 3.982

3.  Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice.

Authors:  Anne-Sophie Dussol; Marie-Odile Joly; Cecile Vercherat; Julien Forestier; Valérie Hervieu; Jean-Yves Scoazec; Catherine Lombard-Bohas; Thomas Walter
Journal:  Cancer       Date:  2015-06-08       Impact factor: 6.860

Review 4.  Exocrine and endocrine pancreatic insufficiency after pancreatic surgery.

Authors:  Stefan Kahl; Peter Malfertheiner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2004-10       Impact factor: 3.043

5.  Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Authors:  Eric Raymond; Laetitia Dahan; Jean-Luc Raoul; Yung-Jue Bang; Ivan Borbath; Catherine Lombard-Bohas; Juan Valle; Peter Metrakos; Denis Smith; Aaron Vinik; Jen-Shi Chen; Dieter Hörsch; Pascal Hammel; Bertram Wiedenmann; Eric Van Cutsem; Shem Patyna; Dongrui Ray Lu; Carolyn Blanckmeister; Richard Chao; Philippe Ruszniewski
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

6.  Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.

Authors:  Oriol Casanovas; Daniel J Hicklin; Gabriele Bergers; Douglas Hanahan
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

7.  Outcome after laparoscopic enucleation for non-functional neuroendocrine pancreatic tumours.

Authors:  Laureano Fernández-Cruz; Víctor Molina; Rodrigo Vallejos; Enrique Jiménez Chavarria; Miguel-Angel López-Boado; Joana Ferrer
Journal:  HPB (Oxford)       Date:  2012-01-09       Impact factor: 3.647

8.  Aggressive surgery for metastatic liver neuroendocrine tumors.

Authors:  Jeffrey A Norton; Robert S Warren; Mary G Kelly; Marlene B Zuraek; Robert T Jensen
Journal:  Surgery       Date:  2003-12       Impact factor: 3.982

9.  Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management.

Authors:  Louis C Lee; Clive S Grant; Diva R Salomao; Joel G Fletcher; Naoki Takahashi; Jeff L Fidler; Michael J Levy; Marianne Huebner
Journal:  Surgery       Date:  2012-10-24       Impact factor: 3.982

10.  Surgical treatment of pancreatic endocrine neoplasms.

Authors:  Fernando Gomez-Rivera; Ashley E Stewart; J Pablo Arnoletti; Selwyn Vickers; Kirby I Bland; Martin J Heslin
Journal:  Am J Surg       Date:  2007-04       Impact factor: 2.565

View more
  3 in total

1.  A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients.

Authors:  Mohammad Y Zaidi; Alexandra G Lopez-Aguiar; Jeffrey M Switchenko; Joseph Lipscomb; Valentina Andreasi; Stefano Partelli; Adriana C Gamboa; Rachel M Lee; George A Poultsides; Mary Dillhoff; Flavio G Rocha; Kamran Idrees; Clifford S Cho; Sharon M Weber; Ryan C Fields; Charles A Staley; Massimo Falconi; Shishir K Maithel
Journal:  Ann Surg       Date:  2019-09       Impact factor: 12.969

2.  Real-world treatment patterns in advanced pancreatic neuroendocrine tumors in the era of targeted therapy: perspectives from an academic tertiary center and community oncology practices.

Authors:  Maurice Herring; Lynn Huynh; Mei Sheng Duh; Francis Vekeman; Audrey Tiew; Maureen Neary; Emily Bergsland
Journal:  Med Oncol       Date:  2017-04-09       Impact factor: 3.064

Review 3.  Pancreatic neuroendocrine tumors: the basics, the gray zone, and the target.

Authors:  Dionysia Kelgiorgi; Christos Dervenis
Journal:  F1000Res       Date:  2017-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.